Sanofi Operating Expenses Growth & History (SAN)

Sanofi's operating expenses was €27.32B for fiscal 2025.

View full Sanofi company overview

Sanofi annual operating expenses history

Sanofi annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31€27.32B€3.49B+14.66%
20242024-12-31€23.83B€1.80B+8.17%
20232023-12-31€22.03B€3.51B+18.97%
20222022-12-31€18.52B−€277.0M−1.47%
20212021-12-31€18.79B€7.70B+69.36%
20202020-12-31€11.10B−€11.50B−50.90%
20192019-12-31€22.60B€3.04B+15.51%
20182018-12-31€19.57B€762.0M+4.05%
20172017-12-31€18.80B€1.34B+7.67%
20162016-12-31€17.46B−€854.0M−4.66%
20152015-12-31€18.32B

Sanofi operating expenses trends

Over the last five fiscal years, Sanofi's operating expenses increased from €11.10B to €27.32B, a change of €16.23B. The latest reported quarter, Q2 2026, shows €6.90B.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Sanofi source filings ↗

Community posts

It’s quiet here.

No posts about SAN yet. Start the conversation.

Write the first post